Author: biocytogen

American Association for Cancer Research (AACR) Annual Meeting 2019

Date: March 29 - April 3, 2019
Location: Atlanta, Georgia

Biocytogen Highlights 10 Posters highlight new IO targets (e.g. CTLA-4, OX40, CD3e), preclinical services, PK/PD studies, and antibody screening platform will be presented at AACR. Time Abstract Full Name Abstract # Board # Category Apr 1 8AM – 12PM Anti-SIRPα antibodies as a   potential weapon for cancer immunotherapy via accelerated screening in   humanized […]

Read More

Biocytogen seminar at the University of Western Ontario

Date: October 2, 2018
Location: London, ON, Canada

Dr. James Jin, the Vice President of Biocytogen, will hold a seminar at the University of Western Ontario in London, Canada. This seminar mainly focuses on CRISPR/Cas9 based Extreme Genome Editing (EGE) Technology developed by Biocytogen and its Applications. The seminar is hosted by Dr. Cindy(Qing) Shao from the University of Western Ontario. Welcome to […]

Read More

Immuno-Oncology (IO) Summit 2018

August 4, 2018

Biocytogen attended Immuno-Oncology (IO) Summit 2018 congress in Boston, MA, Aug 28 – Aug 31. IO Summit has become the leading annual meeting focusing on the latest applied research. This conference covers immunomodulatory antibody engineering and emerging immuno-oncology targets, combination immunotherapy, preclinical and translational IO, predictive biomarkers and companion diagnostics, adoptive T cell therapy, oncolytic […]

Read More

Back to top